Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.

Shen J, Liao J, Guarnera MA, Fang H, Cai L, Stass SA, Jiang F.

J Thorac Oncol. 2014 Jan;9(1):33-40. doi: 10.1097/JTO.0000000000000025.

2.

Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.

Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F.

Lung Cancer. 2010 Feb;67(2):170-6. doi: 10.1016/j.lungcan.2009.04.004. Epub 2009 May 14.

3.

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.

Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, Jiang F.

BMC Cancer. 2011 Aug 24;11:374. doi: 10.1186/1471-2407-11-374.

4.

Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.

Xing L, Su J, Guarnera MA, Zhang H, Cai L, Zhou R, Stass SA, Jiang F.

Clin Cancer Res. 2015 Jan 15;21(2):484-9. doi: 10.1158/1078-0432.CCR-14-1873.

5.

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers.

Xing L, Todd NW, Yu L, Fang H, Jiang F.

Mod Pathol. 2010 Aug;23(8):1157-64. doi: 10.1038/modpathol.2010.111. Epub 2010 Jun 4.

6.

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.

Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F.

Int J Cancer. 2010 Dec 15;127(12):2870-8. doi: 10.1002/ijc.25289.

7.

Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer.

Li N, Ma J, Guarnera MA, Fang H, Cai L, Jiang F.

J Cancer Res Clin Oncol. 2014 Jan;140(1):145-50. doi: 10.1007/s00432-013-1555-5. Epub 2013 Nov 27.

8.

Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.

Tumour Biol. 2016 Jun;37(6):7777-84. doi: 10.1007/s13277-015-4608-3. Epub 2015 Dec 22.

PMID:
26695145
9.

Test performance of sputum microRNAs for lung cancer: a meta-analysis.

Liao QB, Guo JQ, Zheng XY, Zhou ZF, Li H, Lai XY, Ye JF.

Genet Test Mol Biomarkers. 2014 Aug;18(8):562-7. doi: 10.1089/gtmb.2014.0005. Epub 2014 Jun 3. Review.

PMID:
24892736
10.

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.

Tang D, Shen Y, Wang M, Yang R, Wang Z, Sui A, Jiao W, Wang Y.

Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.

PMID:
23462458
11.

Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.

Su Y, Fang H, Jiang F.

Clin Epigenetics. 2016 Oct 19;8:109. eCollection 2016.

12.

miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.

J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.

13.

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.

Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, Jiang Z, Fang H, Katz RL, Jiang F.

Lab Invest. 2011 Apr;91(4):579-87. doi: 10.1038/labinvest.2010.194. Epub 2010 Nov 29.

14.

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.

Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN, Pass HI.

J Thorac Oncol. 2013 Sep;8(9):1156-62. doi: 10.1097/JTO.0b013e318299ac32.

15.

Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.

Roa WH, Kim JO, Razzak R, Du H, Guo L, Singh R, Gazala S, Ghosh S, Wong E, Joy AA, Xing JZ, Bedard EL.

Clin Invest Med. 2012 Oct 6;35(5):E271.

PMID:
23043708
16.

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U.

J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13. Erratum in: J Clin Oncol. 2014 May 10;32(14):1520.

17.

Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.

Wang P, Yang D, Zhang H, Wei X, Ma T, Cheng Z, Hong Q, Hu J, Zhuo H, Song Y, Jia C, Jing F, Jin Q, Bai C, Mao H, Zhao J.

Clin Lung Cancer. 2015 Jul;16(4):313-9.e1. doi: 10.1016/j.cllc.2014.12.006. Epub 2014 Dec 24.

PMID:
25639977
18.

Serum microRNA biomarkers for detection of non-small cell lung cancer.

Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA.

PLoS One. 2012;7(2):e32307. doi: 10.1371/journal.pone.0032307. Epub 2012 Feb 28.

19.

Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer.

Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA.

Lung Cancer. 2009 Oct;66(1):58-63. doi: 10.1016/j.lungcan.2009.01.004. Epub 2009 Jan 31.

20.

Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.

Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST, Kang MH, Son SM, Lee YM, Choi SY, Yun SJ, Kim WJ, Lee OJ.

Int J Cancer. 2013 Aug 1;133(3):645-52. doi: 10.1002/ijc.28054. Epub 2013 Feb 25.

Supplemental Content

Support Center